Friday, October 31, 2025 10/31/2025

Impact of intra-host population structure on influenza virus antigenic evolution

Award Number: R01AI165644
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/09/2021
PERIOD OF PERFORMANCE END DATE: 11/30/2026

Group Awards By:

View Award Description

Impact of intra-host population structure on influenza virus antigenic evolution - SUMMARY At the global population level, seasonal influenza A virus (IAV) evolution is characterized by repeated selective sweeps in which novel antigenic variants that escape antibody responses replace previously circulating strains. Despite this clear pattern at a population level, selection of antigenic variants is not typically seen within individuals with acute IAV infection. This apparent disconnect between evolutionary processes at population and within-host scales contributes to the challenge of predicting evolutionary outcomes. The processes that impede IAV selection within the host, and their potency, have not been examined systematically. To address this knowledge gap, we will test the central hypothesis that the genetic structure of within-host viral populations plays a major role in defining the likelihood that a beneficial mutation becomes fixed. In particular, we hypothesize that the fate of a highly fit variant virus is shaped by its initial prevalence in the inoculum (quantitative structure), the timing with which it arises de novo (temporal structure), its location within the infected tissue (spatial structure) and the presence or absence of competing variants (clonal interference). In turn, we predict that onward transmission of a beneficial variant will rely on a combination of these factors and the stringency of the transmission bottleneck. We furthermore propose that the severity of the bottleneck is modulated by pre-existing immunity in the host. To test these hypotheses, we will monitor the dynamics of mixed viral populations containing a seasonal IAV and one or two HA antigenic variants thereof within individual guinea pigs and between transmission partners. Partial immunity will be induced with vaccination to yield a model in which the antigenic variants have a selective advantage. Distinct sequence barcodes will be included in the HA and NA genes of each virus to allow sensitive detection of genetic bottlenecks. Tracking barcodes in both HA and NA will allow genetic linkage to be assessed. The wild type and antigenic variant viruses will be combined in vivo with various quantitative, temporal and spatial structures and then barcode dynamics will be monitored by sequencing. With this approach, we will perform a systematic evaluation of the consequences of population genetic structure for viral evolutionary dynamics. This well-controlled and systematic approach will allow identification of processes that impede selection within and between individual hosts, providing much needed insight into the forces shaping IAV evolution where it begins.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $385,206 )
2025	2025	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Allergy and Infectious Diseases Research	001	4	5/8/2025	NON-COMPETING CONTINUATION	$0
2025	2025	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Allergy and Infectious Diseases Research	000	4	11/11/2024	NON-COMPETING CONTINUATION	$385,206
														Subtotal = $385,206

Issue Date FY: 2024 ( Subtotal = $385,755 )
2024	2024	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Allergy and Infectious Diseases Research	001	3	5/15/2024	NON-COMPETING CONTINUATION	$38,575
2024	2024	EMORY UNIVERSITY	201 DOWMAN DR	ATLANTA	GA	30322	DEKALB	USA	Allergy and Infectious Diseases Research	000	3	11/8/2023	NON-COMPETING CONTINUATION	$347,180
														Subtotal = $385,755

Issue Date FY: 2023 ( Subtotal = $386,255 )
2023	2023	EMORY UNIVERSITY	201 DOWMAN DR	ATLANTA	GA	30322	DEKALB	USA	Allergy and Infectious Diseases Research	000	2	11/22/2022	NON-COMPETING CONTINUATION	$386,255
														Subtotal = $386,255

Issue Date FY: 2022 ( Subtotal = $386,709 )
2022	2022	EMORY UNIVERSITY	201 DOWMAN DR	ATLANTA	GA	30322	DEKALB	USA	Allergy and Infectious Diseases Research	000	1	12/9/2021	NEW	$386,709
														Subtotal = $386,709

Grand Total All Awards = $1,543,925

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Impact of intra-host population structure on influenza virus antigenic evolution

Award Number: R01AI165644

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/09/2021

PERIOD OF PERFORMANCE END DATE: 11/30/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer